- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03760783
The Effects of Microgravity on Human Sperm
It has been described that microgravity affects cellular and molecular structures. Cell membrane, cytoskeleton, cytoplasm and nucleus have been found to be sensible to gravitational changes. Alterations in the male and female reproductive systems have also been reported in mouse and other animals. The effects of microgravity on human reproductive cells remain unknown.
The main objective of this experimental study is to investigate the effect of simulated microgravity in human male reproductive cells under in vitro conditions. Induced microgravity conditions will be obtained with a smaller single-engine aerobatic aircraft that can provide parabolic flights.
The main parameters to be analyzed are: sperm motility, vitality, DNA fragmentation and apoptosis.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08028
- Women's Health Dexeus Departament d'Obstetrícia, Ginecologia i Reproducció
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy volunteers (men)
- Who accepted to take part in the study
- Who gave their written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Effect of microgravity on human sperm
Simulated microgravity flight
|
Sperm analysis (total motility M/ml; grade a+b sperm M/ml, vitality, DNA Frag and apoptosis) will be measured on ground at 1g before the flight and after flight were sperm samples have been exposed to simulated microgravity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sperm motility
Time Frame: In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
The percentage of normal spermatozoa in terms of motility grades a,b,c according to WHO
|
In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
|
Change Sperm Morphology
Time Frame: In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
The percentage of normal spermatozoa in terms of morphology is assessed by staining.
The lower reference limit for normal forms is 4% (WHO 2010).
|
In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
|
Change Sperm Vitality
Time Frame: In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
The percentage of live spermatozoa is assessed by identifying those with an intact cell membrane, from dye exclusion.
The lower reference limit for vitality (membrane-intact spermatozoa) is 58% (WHO 2010).
|
In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
|
Change in Sperm DNA Fragmentation
Time Frame: In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
Sperm DNA fragmentation is evaluated by Halosperm® kit, based on the SCD technique, patented by Halotech. This kit is based on a controlled DNA denaturation process to facilitate the subsequent removal of the proteins contained in each spermatozoon. In this way, normal spermatozoa create halos formed by loops of DNA at the head of the sperm, which are not present in those with damaged DNA. Thresholds for frequency of Sperm DNA Fragmentation (SDF) have been suggested by Dr. Evenson et al. (Evenson and Nixon, Reprod Biomed Online 12:466-472, 2006). The authors reported that couples with no known infertility problems were more likely to achieve a pregnancy/delivery if the DNA fragmentation index (DFI) was <30%. |
In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
|
Change Sperm APOPTOSIS (Annexin V )
Time Frame: In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
Annexin V recognizes an antigen (externalized phosphatidylserine, EPS) in the plasma membrane of apoptotic cells. Apoptotic cell depletion begins with the magnetic labeling of apoptotic cells by the MACS® ART Annexin V Reagent. The labeled cells are then passed through a separation column located in a fixed magnetic field. Unwanted cells are selectively retained in the column. Living spermatozoa are not labeled by the reagent, so they pass through the column and are collected for later use. In our study, after collecting living spermatozoa we also collected the retained apoptotic spermatozoa for comparing the concentration (M/ml) of apoptotic vs no apoptotic cells. |
In earth gravity g=1(<4 hours before Parabolic flight) and after simulated microgravity exposure (<4 hours Post Parabolic Flight)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FSD-ATM-2018-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Semen Quality
-
Anhui Medical UniversityThe First Affiliated Hospital of Anhui Medical UniversityCompleted
-
Horsens HospitalVidens- og Forskningscenter for Alternativ BehandlingCompleted
-
Aalborg UniversityAalborg University HospitalCompleted
-
Hamad Medical CorporationFairhaven HealthUnknownInfertility, Male | Antioxidants | Semen QualityQatar
-
Rajavithi HospitalRecruitingAutologous Platelet-rich Plasma Supplement | Sperm Cryopreservation | Post-cryopreserved Sperm Quality | Semen AnalysisThailand
-
ReproNovo ApsRecruitingSemen QualityUnited States
-
Copenhagen University Hospital at HerlevRigshospitalet, DenmarkTerminatedInfertility | Varicocele | Semen QualityDenmark
-
CONRADJohns Hopkins University; Eastern Virginia Medical SchoolCompleted
-
ART Fertility Clinics LLCRecruitingICSI | PGT-A | Semen AnalysisUnited Arab Emirates
-
VIVUS LLCCompletedAvanfil ADME | Semen Exposure | Sperm FunctionUnited States
Clinical Trials on Parabolic flight
-
University Hospital, CaenCompleted
-
University Hospital, CaenUnknown
-
University Hospital, CaenUnknown
-
University Hospital, CaenCompleted
-
University Hospital, CaenUnknown
-
University Hospital, CaenUnknownHealthy VolunteersFrance
-
University Hospital, CaenCompleted
-
University Hospital, CaenUnknown
-
University Hospital, CaenNovespaceCompletedHealthy VolunteersFrance
-
University Hospital, CaenUnknownHealthy VolunteersFrance